Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex Vivo

This publication has 11 references indexed in Scilit:

• Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin
  Blood, 1994
• Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells
  Blood, 1994
• Release of tumor cells from bone marrow [editorial; comment]
  Blood, 1994
• Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
  Blood, 1994
• Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
  Journal of Clinical Oncology, 1994
• Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients
  The Lancet, 1993
• Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin
  British Journal of Haematology, 1993
• Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin
  Blood, 1993
• Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
  The Lancet, 1992
• The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies [editorial]
  Blood, 1991